drug approval process

1:11PM
Printer-friendly version
New review rules—the impact on drug access in Canada

In 2017, the federal government introduced new regulations for the drug review board.


11:39AM
Printer-friendly version
Delayed drug approvals in Canada—here’s why

New drugs are approved later in Canada than in the United States and European Union.


10:38AM
Printer-friendly version
Approving new drugs in Canada—a 30-year review

Regardless of their potential impact on patient health, drug approval times in Canada were longer than in other countries.


1:05PM
Printer-friendly version
Canada should permanently expand drug approval process in post-COVID world

Accepting FDA approvals could lead to earlier marketing availability in Canada.


2:00AM
Printer-friendly version

Innovative new medicines can have a profound impact on the health and wellbeing of those stricken with illness. Unfortunately, Canadians are often denied these benefits for months, if not years, while they wait for their government to approve drugs already deemed safe and effective by regulators in the European Union and United States. Smarter regulation could save resources, reduce patient suffering, and improve the lives of Canadians.


2:00AM
Printer-friendly version

New medicines are a central component of modern medical care, treating illness effectively, providing more comfortable treatment regimes, extending life and reducing disability, and sometimes offering new treatment options where none previously existed. However, these benefits come with the potential for harm, which is why governments around the world regulate access to new medicines.